Details for New Drug Application (NDA): 076850
✉ Email this page to a colleague
NDA 076850 describes TERCONAZOLE, which is a drug marketed by Fougera Pharms, Fougera Pharms Inc, Taro, and Padagis Israel, and is included in seven NDAs. It is available from eight suppliers. Additional details are available on the TERCONAZOLE profile page.
The generic ingredient in TERCONAZOLE is terconazole. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the terconazole profile page.
The generic ingredient in TERCONAZOLE is terconazole. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the terconazole profile page.
Summary for 076850
| Tradename: | TERCONAZOLE |
| Applicant: | Fougera Pharms |
| Ingredient: | terconazole |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;VAGINAL | Strength | 80MG | ||||
| Approval Date: | Jul 12, 2006 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
